TY  - RPRT
TI  - DNA2 variant analysis supports the nuclease activity as a preferred therapeutic target
AU  - Baillie, K. E.
AU  - Zhang, S. C.
AU  - Mathew, V.
AU  - Nations, T.
AU  - Koneru, B.
AU  - Stirling, P. C.
PY  - 2025
DO  - 10.64898/2025.12.14.693011
UR  - https://www.biorxiv.org/content/10.64898/2025.12.14.693011v1
ID  - 10.64898/2025.12.14.693011
ER  -